Expressing support for the designation of the week of May 3, 2026, through May 9, 2026, as "Tardive Dyskinesia Awareness Week".

This bill would designate May 3–9, 2026 as Tardive Dyskinesia Awareness Week to raise public and medical awareness of a movement disorder tied to prolonged use of dopamine receptor blocking drugs. It notes TD affects about 600,000 people in the United States and that roughly 60% of cases go undiagnosed, encourages clinicians to screen and monitor patients on antipsychotics and antiemetics, and urges people to learn symptoms so recognition and available FDA-approved treatments for adults can improve quality of life.